These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 9868986

  • 1. Improving glycaemic control with current therapies.
    Birkeland KI.
    Diabet Med; 1998; 15 Suppl 4():S13-9. PubMed ID: 9868986
    [Abstract] [Full Text] [Related]

  • 2. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL, Figgitt DP.
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [Abstract] [Full Text] [Related]

  • 3. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ, Bailey CJ.
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [Abstract] [Full Text] [Related]

  • 4. Type II diabetes mellitus.
    Edelman SV.
    Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190
    [Abstract] [Full Text] [Related]

  • 5. Insulin therapy in type 2 diabetes.
    Mudaliar S, Edelman SV.
    Endocrinol Metab Clin North Am; 2001 Dec; 30(4):935-82. PubMed ID: 11727406
    [Abstract] [Full Text] [Related]

  • 6. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
    van Raalte DH, Verchere CB.
    Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962
    [Abstract] [Full Text] [Related]

  • 7. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications.
    Porte D.
    Diabetes Metab Res Rev; 2001 Sep; 17(3):181-8. PubMed ID: 11424231
    [Abstract] [Full Text] [Related]

  • 8. Optimising therapy for insulin-treated type 2 diabetes mellitus.
    Hermann LS.
    Drugs Aging; 2000 Oct; 17(4):283-94. PubMed ID: 11087006
    [Abstract] [Full Text] [Related]

  • 9. Longitudinal study on glycaemic control and quality of life in patients with Type 2 diabetes mellitus referred for intensified control.
    Goddijn PP, Bilo HJ, Feskens EJ, Groeniert KH, van der Zee KI, Meyboom-de Jong B.
    Diabet Med; 1999 Jan; 16(1):23-30. PubMed ID: 10229289
    [Abstract] [Full Text] [Related]

  • 10. Potential new treatments for type 2 diabetes.
    Bailey CJ.
    Trends Pharmacol Sci; 2000 Jul; 21(7):259-65. PubMed ID: 10871894
    [Abstract] [Full Text] [Related]

  • 11. Promising new approaches.
    Reasner CA.
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [Abstract] [Full Text] [Related]

  • 12. The role of oral antidiabetic agents: why and when to use an early-phase insulin secretion agent in Type II diabetes mellitus.
    Standl E, Füchtenbusch M.
    Diabetologia; 2003 Mar; 46 Suppl 1():M30-6. PubMed ID: 12652356
    [Abstract] [Full Text] [Related]

  • 13. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
    Clark HE, Matthews DR.
    Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
    [Abstract] [Full Text] [Related]

  • 14. Approaches to the management of postprandial hyperglycaemia.
    Landgraf R.
    Exp Clin Endocrinol Diabetes; 1999 Sep; 107 Suppl 4():S128-32. PubMed ID: 10522837
    [Abstract] [Full Text] [Related]

  • 15. Before oral agents fail: the case for starting insulin early.
    Marre M.
    Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S25-30. PubMed ID: 12174320
    [Abstract] [Full Text] [Related]

  • 16. Management of type 2 diabetes mellitus in the elderly: special considerations.
    Rosenstock J.
    Drugs Aging; 2001 Sep; 18(1):31-44. PubMed ID: 11232737
    [Abstract] [Full Text] [Related]

  • 17. New frontiers in the management of type 2 diabetes.
    Mudaliar S.
    Indian J Med Res; 2007 Mar; 125(3):275-96. PubMed ID: 17496356
    [Abstract] [Full Text] [Related]

  • 18. Novel approaches to the treatment of hyperglycaemia in type 2 diabetes mellitus.
    Galligan A, Greenaway TM.
    Intern Med J; 2016 May; 46(5):540-9. PubMed ID: 27170238
    [Abstract] [Full Text] [Related]

  • 19. Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial.
    Ritsinger V, Malmberg K, Mårtensson A, Rydén L, Wedel H, Norhammar A.
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):627-33. PubMed ID: 24831989
    [Abstract] [Full Text] [Related]

  • 20. Repaglinide in combination therapy.
    Moses R.
    Diabetes Nutr Metab; 2002 Dec; 15(6 Suppl):33-8. PubMed ID: 12702006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.